SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently garnering significant community attention as traders debate its role in institutional adoption, with many users actively discussing its potential for recovery amidst broader crypto market volatility. Community sentiment remains polarized, featuring a mix of long-term holders focused on staking and developers pushing various meme-based projects on the chain.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community debates its long-term utility versus short-term price action, with significant focus on an upcoming token unlock and high expectations for major partnerships in the pipeline. Investors are actively discussing the project's potential integration with institutional rails like XRP and Stellar, fueling a narrative of long-term holding despite current market volatility.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp (BATL) is trending as retail investors rally around its potential for a short squeeze amid escalating Middle East tensions and rising global oil prices. The community is heavily focused on the geopolitical impact on supply chains and energy infrastructure, with many debating the impact of insider activity versus bullish sentiment regarding energy sector independence.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon stock is currently trending due to a combination of escalating Middle East geopolitical risks impacting AWS cloud infrastructure in Bahrain and increased institutional interest driven by positive analyst target adjustments. While short-term traders are reacting to bearish flow divergence and regional conflict volatility, long-term investors are heavily debating the stock's valuation as a foundational AI play versus broader market concerns over consumer spending and potential recessionary headwinds.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors weigh strong 1Q26 booking momentum and expanding defense sector partnerships against disappointing quarterly revenue and wider-than-expected losses. The community is actively debating the stock's long-term valuation as a speculative "quantum pure-play" while navigating intense volatility driven by competitive pressures from other industry players and broader macroeconomic uncertainty.

Solana Street Bets is not just a memecoin; it's a symbol of creativity, humor, and the power of a united community. Inspired by the infamous /wallstreetbets subreddit. Solana Street Bets is here to put respect on the Wall St originated memes in the industry. Solana Street Bets is a decentralized Solana meme coin inspired by the infamous /wallstreetbets subreddit.

SatoshiStreetBets

SatoshiStreetBets ($SSB) is currently trending as community members rally behind its recent launch, actively pushing for exchange listings and requesting updated charts to track momentum. Investors are highlighting the project's ambitious ecosystem plans and decentralized finance features, while discussions frequently emphasize the potential for long-term growth and the active involvement of the SatoshiStreetBets community.

Global X Funds - Global X Defense Tech ETF

Global X Defense Tech ETF

The Global X Defense Tech ETF is seeing significant momentum as investors capitalize on surging global military spending and persistent geopolitical tensions, with many in the community viewing it as a strategic long-term play for aerospace and autonomous technology. Traders are actively debating the integration of artificial intelligence and robotics into defense platforms, with many highlighting the ETF's diversified exposure to both domestic and international contractors as a key hedge against macroeconomic uncertainty.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna is trending due to surging interest in its European gas fields amid heightened geopolitical instability and supply concerns in the energy sector. Investors are closely monitoring the stock's tight float and high cost-to-borrow fees, with community discussions heavily focused on the potential for a short squeeze and the added leverage provided by the company's warrants.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors react to a significant analyst upgrade and anticipate the upcoming presentation of Phase 3 long-term clinical data at the American Academy of Dermatology conference. The community is actively discussing the stock's potential for acquisition, with ongoing debates centered on whether recent price volatility is driven by institutional accumulation or tactical suppression by market makers.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is surging following FDA approval of Vykat XR to treat hyperphagia in Prader-Willi syndrome patients, marking the first therapy of its kind for this rare disease. The community is actively discussing the stock's significant valuation shift, potential for commercial success, and ongoing speculation regarding its status as a high-conviction buyout candidate for larger pharmaceutical players.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Surgery Partners (NASDAQ:SGRY) Reaches New 1-Year Low - What's Next?

Surgery Partners (NASDAQ:SGRY) Hits New 12-Month Low - Here's Why...

SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES

SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP...

Hudson Bay Capital Management LP Sells 133,637 Shares of Surgery Partners, Inc. $SGRY

Hudson Bay Capital Management LP cut its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 28.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 339,609 shares of the company's stock aft...

Surgery Partners (NASDAQ:SGRY) Hits New 12-Month Low - Time to Sell?

Surgery Partners (NASDAQ:SGRY) Sets New 1-Year Low - Here's Why...

SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES

SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES PR...

Jason Eric Evans Sells 20,400 Shares of Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) CEO Jason Eric Evans sold 20,400 shares of the business's stock in a transaction on Monday, March 16th. The shares were sold at an average price...

Jennifer Baldock Sells 5,798 Shares of Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) insider Jennifer Baldock sold 5,798 shares of the firm's stock in a transaction on Thursday, March 12th. The stock was sold at an average price...

David Doherty Sells 8,867 Shares of Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) CFO David Doherty sold 8,867 shares of the stock in a transaction on Monday, March 16th. The stock was sold at an average price of $12.50, for a...

Insider Selling: Surgery Partners (NASDAQ:SGRY) Insider Sells 3,657 Shares of Stock

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) insider Marissa Brittenham sold 3,657 shares of Surgery Partners stock in a transaction on Friday, March 13th. The stock was sold at an average...

Surgery Partners (NASDAQ:SGRY) Insider Danielle Burkhalter Sells 3,469 Shares

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) insider Danielle Burkhalter sold 3,469 shares of the business's stock in a transaction on Friday, March 13th. The shares were sold at an average...

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Surgery Partners Inc

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.12	--	--	N/A
Q4 '25	$0.30	$0.12	-60.55%	MISSED
Q3 '25	$0.20	$0.13	-35.92%	MISSED
Q2 '25	$0.18	$0.17	-3.70%	MISSED
Q1 '25	$0.07	$0.04	-39.47%	MISSED

SGRY
Surgery Partners Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest SGRY News

SGRYSurgery Partners Inc